Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-03 07:37:18 - browse：722

Cell and gene therapy sign seen at a conference. -- biotech coverage from STAT — Jonathan Wosen for STAT

CARLSBAD, Calif. — Biotech CEOs leading cell and gene therapy companies spoke frankly at a conference here last week about the tough choices they’re making to preserve limited cash amid the industry’s ongoing slowdown.

The company leaders said that they’ve felt added pressure to use smaller teams to work quickly on fewer projects, and at times to partner with outside firms that have specific manufacturing and research expertise. Not all of these changes are bad, they added, noting that efficiency is a good trait for a biotech company in any market.

The candid conversation on Thursday was part of Meeting on the Mesa, an annual cell and gene therapy conference held in Carlsbad, in the north of San Diego County. And it provided a glimpse into discussions happening across the life science industry as biotech markets continue a sharp slump that dates back to late 2021.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： In medicine, common shorthands can shortchange care

focus

WSS

Better Therapeutics data on benefit with GLP

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Eight reasons why you should get an updated Covid vaccine

Takeaways from AdvaMed, the largest medical devices conference

Wellcome Trust names Røttingen as its new CEO

STAT Readout Newsletter: Today in biotech, life science news

Wikipedia

Wikipedia

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

As demand for Covid shots wanes, Moderna seeks its next success

Democratic lawmaker calls for 'well

Virginia high school admissions case could be legal follow

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

How one medical school became remarkably diverse

Life sciences deals on track to hit lowest point since 2017

Affirmative action in medical school literally saved lives

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

focus

What the Wegovy shortage looks like for doctors — and for patients

Akero's treatment for NASH falls short in cirrhosis study

In medicine, common shorthands can shortchange care

European regulators recommend Amylyx's ALS drug be rejected

Why workplace violence is so common in health care

European regulators recommend Amylyx's ALS drug be rejected

leisure time

hotspot

focus

knowledge